Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Its job is to move fatty acids into mitochondria, where they can be oxidised, or burned, for energy [1]
Ofev (nintedanib) Disease area(s): Respiratory Manufacturer(s): Boehringer Ingelheim 2024 Sales (USD): $4.07 billion Why it sold so well: In 2024, Boehringer Ingelheims Ofev achieved significant commercial success, with global sales reaching 3.77 billion ($4.07 billion), marking a 7.3% increase at constant exchange rates compared to the previous year
Which struggled with tolerability
- Month 3+: Complete transformation with luminous glowing skin reflecting inner health
Obese individuals from lower socioeconomic backgrounds face additional healthcare costs, spending, on average, over $1,800 more annually than those without obesity
Januvia (sitagliptin) is a DPP-4 inhibitor taken as a once-daily oral tablet
US$ 27.85
US$ 21.28
US$ 27.96
